"What's in a Name? Biotech by Any Other Would Smell as Sweet"

Maxx Chatsko
Biotechnology
September 2020

“What’s in a Name? Biotech by Any Other Would Smell as Sweet”

Maxx's September update describes how living technologies is undergoing an exponential growth curve, and where he believes the greatest opportunities lie for investors.

September 14, 2020

– Advisor: Maxx Chatsko

Industries: Biotechnology

Please log in or subscribe to 7investing Premium to access this advisor update.